SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

NWRN (NWRN) News

Track canonical SquawkNews coverage tagged to NWRN, NWRN. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol NWRN Asset market Sector Markets 90 days 1 Updated Sep 02, 2026, 05:02 AM UTC Open live news feed
L Newron completes screening for ENIGMA-TRS 1 Phase 3 enrollment Newron Pharmaceuticals said it has completed screening for enrollment in its pivotal Phase 3 ENIGMA-TRS 1 study. Evenamide will be used as add-on therapy in patients with treatment-resistant schizophrenia. EQUITY | Sep 02, 2026, 05:02 AM UTC